Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma

NCT02297958 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT02297958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02297958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian Carcinoma
Lead sponsor
Rennes University Hospital
Phase
Observational
Overall status
Completed
Start date
January 15, 2015
Completion date
July 27, 2019
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian carcinoma